A bibliometric and visualization analysis of research trends and hotspots on targeted therapy for breast cancer from

Deqi Wu1, Chi Pan2, Yangying Hu1

  • 1Department of Thyroid and Breast Diagnosis and Treatment Center, Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.

Frontiers in Oncology
|June 19, 2024
PubMed
Abstract

Insights

This bibliometric analysis reveals research trends in targeted breast cancer therapy. The study highlights the USA as the leading country and identifies key researchers and institutions driving advancements in this critical field.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Breast cancer is a leading cause of cancer mortality worldwide.
  • Targeted therapy offers a precise approach by focusing on specific molecular markers.
  • Understanding research trends is crucial for advancing breast cancer treatment.

Purpose of the Study:

  • To conduct a bibliometric analysis of targeted therapy research for breast cancer.
  • To identify current research trends and future directions in the field.
  • To map the landscape of global research output and collaboration.

Main Methods:

  • Bibliometric analysis of 2,258 articles from 2003-2022 using Web of Science.
  • Co-occurrence and clustering analyses with VOSviewer and R's Bibliometrix package.
  • Keyword burst detection using CiteSpace to identify emerging topics.

Main Results:

  • The USA leads in publications, with the University of Texas MD Anderson Cancer Center being the most prolific institution.
  • Dennis J. Slamon and Gabriel N. Hortobagyi are prominent figures in the field.
  • Research predominantly focuses on epidermal growth factor receptor (EGFR) signaling pathways and drug development.

Conclusions:

  • Bibliometric analysis provides insights into the 20-year evolution of targeted breast cancer therapy research.
  • Identified trends and hotspots can guide future research trajectories.
  • The study facilitates the identification of potential collaborators and institutions.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K